BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17959926)

  • 1. The RNA binding protein RNPS1 alleviates ASF/SF2 depletion-induced genomic instability.
    Li X; Niu T; Manley JL
    RNA; 2007 Dec; 13(12):2108-15. PubMed ID: 17959926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of splicing factor ASF/SF2 induces G2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation.
    Li X; Wang J; Manley JL
    Genes Dev; 2005 Nov; 19(22):2705-14. PubMed ID: 16260492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability.
    Li X; Manley JL
    Cell; 2005 Aug; 122(3):365-78. PubMed ID: 16096057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New talents for an old acquaintance: the SR protein splicing factor ASF/SF2 functions in the maintenance of genome stability.
    Li X; Manley JL
    Cell Cycle; 2005 Dec; 4(12):1706-8. PubMed ID: 16294036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability.
    Wang J; Takagaki Y; Manley JL
    Genes Dev; 1996 Oct; 10(20):2588-99. PubMed ID: 8895660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
    Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
    J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
    Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
    J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins.
    Lemaire R; Prasad J; Kashima T; Gustafson J; Manley JL; Lafyatis R
    Genes Dev; 2002 Mar; 16(5):594-607. PubMed ID: 11877379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.
    Molin M; Akusjärvi G
    J Virol; 2000 Oct; 74(19):9002-9. PubMed ID: 10982344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
    Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
    EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.
    Wang J; Xiao SH; Manley JL
    Genes Dev; 1998 Jul; 12(14):2222-33. PubMed ID: 9679066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
    Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
    J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis.
    Verduci L; Simili M; Rizzo M; Mercatanti A; Evangelista M; Mariani L; Rainaldi G; Pitto L
    J Biol Chem; 2010 Dec; 285(50):39551-63. PubMed ID: 20923760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF).
    Sun D; Novotny M; Bulek K; Liu C; Li X; Hamilton T
    Nat Immunol; 2011 Aug; 12(9):853-60. PubMed ID: 21822258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
    Wang J; Manley JL
    RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single RNA recognition motif in splicing factor ASF/SF2 directs it to nuclear sites of adenovirus transcription.
    Lindberg A; Gama-Carvalho M; Carmo-Fonseca M; Kreivi JP
    J Gen Virol; 2004 Mar; 85(Pt 3):603-608. PubMed ID: 14993643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.
    Cáceres JF; Stamm S; Helfman DM; Krainer AR
    Science; 1994 Sep; 265(5179):1706-9. PubMed ID: 8085156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
    Dauksaite V; Akusjärvi G
    Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing.
    Dauksaite V; Akusjärvi G
    J Biol Chem; 2002 Apr; 277(15):12579-86. PubMed ID: 11801589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
    Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.